{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["AML", "PRKACB", "circRNA-DLEU2", "hsa-miR-496"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30037980", "DateCompleted": {"Year": "2019", "Month": "06", "Day": "24"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "22"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "09", "Day": "28"}], "Language": ["eng"], "ELocationID": ["e00259-18", "10.1128/MCB.00259-18"], "Journal": {"ISSN": "1098-5549", "JournalIssue": {"Volume": "38", "Issue": "20", "PubDate": {"Year": "2018", "Month": "Oct", "Day": "15"}}, "Title": "Molecular and cellular biology", "ISOAbbreviation": "Mol Cell Biol"}, "ArticleTitle": "Role of Circular RNA DLEU2 in Human Acute Myeloid Leukemia.", "Abstract": {"AbstractText": ["In the current study, we were interested in exploring the molecular mechanism of circular RNA DLEU2 (circRNA-DLEU2) (hsa_circ_0000488) and microRNA 496 (miR-496), as well as PRKACB, in human acute myeloid leukemia (AML) cell activities. The RNA expression levels of circRNA-DLEU2, hsa-miR-496, and PRKACB were assessed by quantitative real-time PCR (qRT-PCR). The proliferation and apoptosis abilities of the cells were determined by CCK8 assay and flow cytometry analysis. Target relationships between circRNA-DLEU2 and miR-496, as well as PRKACB, were analyzed by luciferase reporter assay and probe assay. Immunoblotting assays were used to detect the protein expression level of PRKACB. We also did <i>in vivo</i> experiments to observe tumor formation after overexpression of circRNA-DLEU2. Our data showed that circRNA-DLEU2 was upregulated in AML tissues and cells, which promoted AML cell proliferation and inhibited cell apoptosis. circRNA-DLEU2 promoted AML tumor formation <i>in vivo</i> miR-496 was inhibited by circRNA-DLEU2 and was downregulated in AML tissues. circRNA-DLEU2 inhibited miR-496 expression and promoted PRKACB expression. miR-496 antagonized the effects of PRKACB on MOLM-13 cell proliferation and apoptosis. Collectively, circRNA-DLEU2 accelerated human AML by suppressing miR-496 and promoting PRKACB expression."], "CopyrightInformation": "Copyright \u00a9 2018 American Society for Microbiology."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, People's Republic of China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University, Xuzhou, Jiangsu Province, People's Republic of China."}], "LastName": "Wu", "ForeName": "Dong-Mei", "Initials": "DM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, People's Republic of China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University, Xuzhou, Jiangsu Province, People's Republic of China."}], "LastName": "Wen", "ForeName": "Xin", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, People's Republic of China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University, Xuzhou, Jiangsu Province, People's Republic of China."}], "LastName": "Han", "ForeName": "Xin-Rui", "Initials": "XR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, People's Republic of China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University, Xuzhou, Jiangsu Province, People's Republic of China."}], "LastName": "Wang", "ForeName": "Shan", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, People's Republic of China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University, Xuzhou, Jiangsu Province, People's Republic of China."}], "LastName": "Wang", "ForeName": "Yong-Jian", "Initials": "YJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, People's Republic of China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University, Xuzhou, Jiangsu Province, People's Republic of China."}], "LastName": "Shen", "ForeName": "Min", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, People's Republic of China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University, Xuzhou, Jiangsu Province, People's Republic of China."}], "LastName": "Fan", "ForeName": "Shao-Hua", "Initials": "SH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, People's Republic of China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University, Xuzhou, Jiangsu Province, People's Republic of China."}], "LastName": "Zhang", "ForeName": "Zi-Feng", "Initials": "ZF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, People's Republic of China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University, Xuzhou, Jiangsu Province, People's Republic of China."}], "LastName": "Shan", "ForeName": "Qun", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, People's Republic of China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University, Xuzhou, Jiangsu Province, People's Republic of China."}], "LastName": "Li", "ForeName": "Meng-Qiu", "Initials": "MQ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, People's Republic of China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University, Xuzhou, Jiangsu Province, People's Republic of China."}], "LastName": "Hu", "ForeName": "Bin", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, MOE Key Laboratory of Model Animal for Disease Study, Model Animal Research Center, Nanjing University, Nanjing, People's Republic of China."}], "LastName": "Chen", "ForeName": "Gui-Quan", "Initials": "GQ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, People's Republic of China lu-jun75@163.com ylzheng@jsnu.edu.cn."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University, Xuzhou, Jiangsu Province, People's Republic of China."}], "LastName": "Lu", "ForeName": "Jun", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, People's Republic of China lu-jun75@163.com ylzheng@jsnu.edu.cn."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University, Xuzhou, Jiangsu Province, People's Republic of China."}], "LastName": "Zheng", "ForeName": "Yuan-Lin", "Initials": "YL"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Mol Cell Biol", "NlmUniqueID": "8109087", "ISSNLinking": "0270-7306"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "DLEU2 lncRNA, human"}, {"RegistryNumber": "0", "NameOfSubstance": "MIRN496 microRNA, human"}, {"RegistryNumber": "0", "NameOfSubstance": "MicroRNAs"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Circular"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Long Noncoding"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Suppressor Proteins"}, {"RegistryNumber": "63231-63-0", "NameOfSubstance": "RNA"}, {"RegistryNumber": "EC 2.-", "NameOfSubstance": "Transferases"}, {"RegistryNumber": "EC 2.7.11.11", "NameOfSubstance": "Cyclic AMP-Dependent Protein Kinase Catalytic Subunits"}, {"RegistryNumber": "EC 2.7.11.11", "NameOfSubstance": "PRKACB protein, human"}], "CommentsCorrectionsList": [{"RefSource": "Mol Cell Biol. 2022 Dec 15;42(12):e0037522. doi: 10.1128/mcb.00375-22", "PMID": "36374201"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["genetics"], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Base Sequence"}, {"QualifierName": [], "DescriptorName": "Case-Control Studies"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["genetics"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Cyclic AMP-Dependent Protein Kinase Catalytic Subunits"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": [], "DescriptorName": "Heterografts"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["genetics", "metabolism", "pathology"], "DescriptorName": "Leukemia, Myeloid, Acute"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "MicroRNAs"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": [], "DescriptorName": "Models, Genetic"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "RNA"}, {"QualifierName": [], "DescriptorName": "RNA, Circular"}, {"QualifierName": [], "DescriptorName": "RNA, Long Noncoding"}, {"QualifierName": [], "DescriptorName": "Transferases"}, {"QualifierName": ["genetics"], "DescriptorName": "Tumor Suppressor Proteins"}, {"QualifierName": [], "DescriptorName": "Up-Regulation"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Wen S, Wang J, Liu P, Li Y, Lu W, Hu Y, Liu J, He Z, Huang P. 2018. Novel combination of histone methylation modulators with therapeutic synergy against acute myeloid leukemia in vitro and in vivo. Cancer Lett 413:35\u201345. doi:10.1016/j.canlet.2017.10.015.", "ArticleIdList": ["10.1016/j.canlet.2017.10.015", "29069576"]}, {"Citation": "Sill H, Olipitz W, Zebisch A, Schulz E, Wolfler A. 2011. Therapy-related myeloid neoplasms: pathobiology and clinical characteristics. Br J Pharmacol 162:792\u2013805. doi:10.1111/j.1476-5381.2010.01100.x.", "ArticleIdList": ["10.1111/j.1476-5381.2010.01100.x", "PMC3042191", "21039422"]}, {"Citation": "Uchida H, Inokuchi K, Watanabe R, Tokuhira M, Kizaki M. 2008. New therapeutic approaches to acute myeloid leukemia. Expert Opin Drug Discov 3:689\u2013706. doi:10.1517/17460441.3.6.689.", "ArticleIdList": ["10.1517/17460441.3.6.689", "23506149"]}, {"Citation": "Li W, Zhong C, Jiao J, Li P, Cui B, Ji C, Ma D. 2017. Characterization of hsa_circ_0004277 as a new biomarker for acute myeloid leukemia via circular RNA profile and bioinformatics analysis. Int J Mol Sci 18:E597. doi:10.3390/ijms18030597.", "ArticleIdList": ["10.3390/ijms18030597", "PMC5372613", "28282919"]}, {"Citation": "Sabattini E, Bacci F, Sagramoso C, Pileri SA. 2010. WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica 102:83\u201387.", "ArticleIdList": ["21171509"]}, {"Citation": "Briedigkeit H, Halle E. 1989. Calculated antimicrobial chemotherapy from the viewpoint of the clinical microbiologist. Z Arztl Fortbild 83:295\u2013299.", "ArticleIdList": ["2660431"]}, {"Citation": "Szabo L, Morey R, Palpant NJ, Wang PL, Afari N, Jiang C, Parast MM, Murry CE, Laurent LC, Salzman J. 2015. Statistically based splicing detection reveals neural enrichment and tissue-specific induction of circular RNA during human fetal development. Genome Biol 16:126. doi:10.1186/s13059-015-0690-5.", "ArticleIdList": ["10.1186/s13059-015-0690-5", "PMC4506483", "26076956"]}, {"Citation": "Vausort M, Salgado-Somoza A, Zhang L, Leszek P, Scholz M, Teren A, Burkhardt R, Thiery J, Wagner DR, Devaux Y. 2016. Myocardial infarction-associated circular RNA predicting left ventricular dysfunction. J Am Coll Cardiol 68:1247\u20131248. doi:10.1016/j.jacc.2016.06.040.", "ArticleIdList": ["10.1016/j.jacc.2016.06.040", "27609688"]}, {"Citation": "Zheng Q, Bao C, Guo W, Li S, Chen J, Chen B, Luo Y, Lyu D, Li Y, Shi G, Liang L, Gu J, He X, Huang S. 2016. Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs. Nat Commun 7:11215. doi:10.1038/ncomms11215.", "ArticleIdList": ["10.1038/ncomms11215", "PMC4823868", "27050392"]}, {"Citation": "Gao YL, Zhang MY, Xu B, Han LJ, Lan SF, Chen J, Dong YJ, Cao LL. 2017. Circular RNA expression profiles reveal that hsa_circ_0018289 is up-regulated in cervical cancer and promotes the tumorigenesis. Oncotarget 8:86625\u201386633. doi:10.18632/oncotarget.21257.", "ArticleIdList": ["10.18632/oncotarget.21257", "PMC5689712", "29156822"]}, {"Citation": "Zhang H, Wang G, Ding C, Liu P, Wang R, Ding W, Tong D, Wu D, Li C, Wei Q, Zhang X, Li D, Liu P, Cui H, Tang H, Ji F. 2017. Increased circular RNA UBAP2 acts as a sponge of miR-143 to promote osteosarcoma progression. Oncotarget 8:61687\u201361697. doi:10.18632/oncotarget.18671.", "ArticleIdList": ["10.18632/oncotarget.18671", "PMC5617456", "28977896"]}, {"Citation": "Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer M, Loewer A, Ziebold U, Landthaler M, Kocks C, le Noble F, Rajewsky N. 2013. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495:333\u2013338. doi:10.1038/nature11928.", "ArticleIdList": ["10.1038/nature11928", "23446348"]}, {"Citation": "Hirsch S, Blatte TJ, Grasedieck S, Cocciardi S, Rouhi A, Jongen-Lavrencic M, Paschka P, Kronke J, Gaidzik VI, Dohner H, Schlenk RF, Kuchenbauer F, Dohner K, Dolnik A, Bullinger L. 2017. Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemia. Haematologica 102:2039\u20132047. doi:10.3324/haematol.2017.172866.", "ArticleIdList": ["10.3324/haematol.2017.172866", "PMC5709103", "28971903"]}, {"Citation": "L'Abbate A, Tolomeo D, Cifola I, Severgnini M, Turchiano A, Augello B, Squeo G, D'Addabbo P, Traversa D, Daniele G, Lonoce A, Pafundi M, Carella M, Palumbo O, Dolnik A, Muehlematter D, Schoumans J, Van Roy N, De Bellis G, Martinelli G, Merla G, Bullinger L, Haferlach C, Storlazzi CT. 22 February 2018. MYC-containing amplicons in acute myeloid leukemia: genomic structures, evolution, and transcriptional consequences. Leukemia. doi:10.1038/s41375-018-0033-0.", "ArticleIdList": ["10.1038/s41375-018-0033-0", "PMC6170393", "29467491"]}, {"Citation": "Xiao Y, Deng T, Su C, Shang Z. 2017. MicroRNA 217 inhibits cell proliferation and enhances chemosensitivity to doxorubicin in acute myeloid leukemia by targeting KRAS. Oncol Lett 13:4986\u20134994. doi:10.3892/ol.2017.6076.", "ArticleIdList": ["10.3892/ol.2017.6076", "PMC5453027", "28599501"]}, {"Citation": "Balatti V, Pekarky Y, Croce CM. 2015. Role of microRNA in chronic lymphocytic leukemia onset and progression. J Hematol Oncol 8:12. doi:10.1186/s13045-015-0112-x.", "ArticleIdList": ["10.1186/s13045-015-0112-x", "PMC4336680", "25886051"]}, {"Citation": "He L, Hannon GJ. 2004. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5:522\u2013531. doi:10.1038/nrg1379.", "ArticleIdList": ["10.1038/nrg1379", "15211354"]}, {"Citation": "Zhang TJ, Wu DH, Zhou JD, Li XX, Zhang W, Guo H, Ma JC, Deng ZQ, Lin J, Qian J. 2018. Overexpression of miR-216b: prognostic and predictive value in acute myeloid leukemia. J Cell Physiol 233:3274\u20133281. doi:10.1002/jcp.26171.", "ArticleIdList": ["10.1002/jcp.26171", "28884855"]}, {"Citation": "Li Z, Huang H, Li Y, Jiang X, Chen P, Arnovitz S, Radmacher MD, Maharry K, Elkahloun A, Yang X, He C, He M, Zhang Z, Dohner K, Neilly MB, Price C, Lussier YA, Zhang Y, Larson RA, Le Beau MM, Caligiuri MA, Bullinger L, Valk PJ, Delwel R, Lowenberg B, Liu PP, Marcucci G, Bloomfield CD, Rowley JD, Chen J. 2012. Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML. Blood 119:2314\u20132324. doi:10.1182/blood-2011-10-386235.", "ArticleIdList": ["10.1182/blood-2011-10-386235", "PMC3311258", "22251480"]}, {"Citation": "Wang Y, Li Z, He C, Wang D, Yuan X, Chen J, Jin J. 2010. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias. Blood Cells Mol Dis 44:191\u2013197. doi:10.1016/j.bcmd.2009.12.010.", "ArticleIdList": ["10.1016/j.bcmd.2009.12.010", "PMC2829339", "20110180"]}, {"Citation": "Skalhegg BS, Tasken K. 2000. Specificity in the cAMP/PKA signaling pathway. Differential expression, regulation, and subcellular localization of subunits of PKA. Front Biosci 5:D678\u2013D693.", "ArticleIdList": ["10922298"]}, {"Citation": "Chen Y, Gao Y, Tian Y, Tian DL. 2013. PRKACB is downregulated in non-small cell lung cancer and exogenous PRKACB inhibits proliferation and invasion of LTEP-A2 cells. Oncol Lett 5:1803\u20131808. doi:10.3892/ol.2013.1294.", "ArticleIdList": ["10.3892/ol.2013.1294", "PMC3700962", "23833645"]}, {"Citation": "Pashaei E, Pashaei E, Ahmady M, Ozen M, Aydin N. 2017. Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy. PLoS One 12:e0179543. doi:10.1371/journal.pone.0179543.", "ArticleIdList": ["10.1371/journal.pone.0179543", "PMC5484492", "28651018"]}, {"Citation": "Sigloch FC, Burk UC, Biniossek ML, Brabletz T, Schilling O. 2015. miR-200c dampens cancer cell migration via regulation of protein kinase A subunits. Oncotarget 6:23874\u201323889. doi:10.18632/oncotarget.4381.", "ArticleIdList": ["10.18632/oncotarget.4381", "PMC4695158", "26203557"]}, {"Citation": "Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y, Chen N, Sun F, Fan Q. 2010. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res 38:5366\u20135383. doi:10.1093/nar/gkq285.", "ArticleIdList": ["10.1093/nar/gkq285", "PMC2938198", "20423907"]}, {"Citation": "Ivanov A, Memczak S, Wyler E, Torti F, Porath HT, Orejuela MR, Piechotta M, Levanon EY, Landthaler M, Dieterich C, Rajewsky N. 2015. Analysis of intron sequences reveals hallmarks of circular RNA biogenesis in animals. Cell Rep 10:170\u2013177. doi:10.1016/j.celrep.2014.12.019.", "ArticleIdList": ["10.1016/j.celrep.2014.12.019", "25558066"]}, {"Citation": "Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J, Marzluff WF, Sharpless NE. 2013. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 19:141\u2013157. doi:10.1261/rna.035667.112.", "ArticleIdList": ["10.1261/rna.035667.112", "PMC3543092", "23249747"]}, {"Citation": "Morenos L, Chatterton Z, Ng JL, Halemba MS, Parkinson-Bates M, Mechinaud F, Elwood N, Saffery R, Wong NC. 2014. Hypermethylation and down-regulation of DLEU2 in paediatric acute myeloid leukaemia independent of embedded tumour suppressor miR-15a/16-1. Mol Cancer 13:123. doi:10.1186/1476-4598-13-123.", "ArticleIdList": ["10.1186/1476-4598-13-123", "PMC4050407", "24885794"]}, {"Citation": "Kasar S, Underbayev C, Yuan Y, Hanlon M, Aly S, Khan H, Chang V, Batish M, Gavrilova T, Badiane F, Degheidy H, Marti G, Raveche E. 2014. Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a/16-1 in chronic lymphocytic leukemia. Oncogene 33:3307\u20133315. doi:10.1038/onc.2013.291.", "ArticleIdList": ["10.1038/onc.2013.291", "PMC4508006", "23995789"]}, {"Citation": "Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, Kjems J. 2013. Natural RNA circles function as efficient microRNA sponges. Nature 495:384\u2013388. doi:10.1038/nature11993.", "ArticleIdList": ["10.1038/nature11993", "23446346"]}, {"Citation": "Zhong Z, Huang M, Lv M, He Y, Duan C, Zhang L, Chen J. 2017. Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway. Cancer Lett 403:305\u2013317. doi:10.1016/j.canlet.2017.06.027.", "ArticleIdList": ["10.1016/j.canlet.2017.06.027", "28687357"]}, {"Citation": "Chen L, Zhang S, Wu J, Cui J, Zhong L, Zeng L, Ge S. 2017. circRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family. Oncogene 36:4551\u20134561. doi:10.1038/onc.2017.89.", "ArticleIdList": ["10.1038/onc.2017.89", "PMC5558096", "28368401"]}]}], "History": [{"Year": "2018", "Month": "5", "Day": "21"}, {"Year": "2018", "Month": "7", "Day": "16"}, {"Year": "2018", "Month": "7", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "6", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "7", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "3", "Day": "28"}], "PublicationStatus": "epublish", "ArticleIdList": ["30037980", "PMC6168983", "10.1128/MCB.00259-18", "MCB.00259-18"]}}]}